Johns Hopkins Technology Ventures (JHTV), the technology transfer and commercialization arm of Johns Hopkins University that translates academic discoveries in healthcare and bioengineering into products and services benefiting society, has promoted Mohit Ganguly, Ph.D., to Senior Technology Licensing Associate. The promotion recognizes Ganguly’s growing role helping bring university-developed technologies to industry partners in the fields of healthcare and bioengineering.
About Mohit Ganguly, Ph.D.
Ganguly’s promotion reflects both his track record and the trust JHTV has placed in him to take on people management responsibilities, as he steps into a role with expanded oversight of the licensing process behind the university’s innovation pipeline. His work sits at the intersection of cutting-edge science and commercialization strategy, identifying and protecting intellectual property, securing development funding, and negotiating licenses that connect Johns Hopkins research with the industry partners positioned to bring it to market.
Over his two and a half years at JHTV, Ganguly has supported more than 100 innovators across over 300 technologies and negotiated more than 40 licensing agreements, work spanning technology fields well beyond the scope of his own doctoral training. Before joining JHTV, he spent nearly three years as a Licensing Associate at George Mason University, where he managed a portfolio of roughly 200 healthcare and bioengineering technologies, helped double the university’s invention disclosures, and initiated and maintained licenses for numerous startups and industrial collaborators. In recognition of that work, he was awarded the Susan Riley Keyes Fellowship by the Association of University Technology Managers (AUTM) — one of only four awarded nationally — and went on to mentor the following class of fellows.
Ganguly’s path into technology transfer began with a Patents2Products Fellowship at the University of Memphis, where he evaluated digital health and infectious disease technologies for commercialization potential and worked directly with inventors to develop minimum viable products, and a stint as a Life Science Consultant at Putnam Associates, where he developed market access and launch strategy insights for clients across oncology, gene therapy, and vaccines. He holds a Ph.D. in Bioengineering and Biomedical Engineering from Vanderbilt University, where his research focused on infrared neural modulation, a Master of Science in Biomedical/Medical Engineering from the Florida Institute of Technology, and a Bachelor of Technology in Biotechnology from the Indian Institute of Technology, Guwahati.
Announcing the promotion, Ganguly reflected on the milestone and what lies ahead in a LinkedIn post: “Every day, I get to work at the bleeding edge of innovations and breakthroughs that may one day become a new drug or diagnostic product. No two negotiations are alike, and each agreement helps me develop a deeper appreciation of how different systems can work together to foster an innovation ecosystem. I will now be managing for the first time, and I’m excited to step into this new chapter.”
About Johns Hopkins Technology Ventures
Johns Hopkins Technology Ventures is the commercialization and entrepreneurship hub of Johns Hopkins University, responsible for fostering a rich innovation ecosystem and bringing Johns Hopkins discoveries to market. JHTV helps innovators and entrepreneurs safeguard and commercialize intellectual property, develop startups into sustainable ventures, and forge strategic collaborations with industry across fields including diagnostics, therapeutics, medical devices, digital health, and precision medicine. With more than 1,900 licensed technologies, over 150 commercial startups formed, and more than $4 billion in licensing revenues generated to date, JHTV plays a central role in maximizing the societal impact of Johns Hopkins’ research, supported by programs including FastForward, the Social Innovation Lab, and the Commercialization Academy.
